levels < levodopa < lewy

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 42.
[0-20] [0 - 20][0 - 42][20-40]

Ident.	Authors (with country if any)	Title
000145 (2013)	Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Alain Destée [France] ; Nobutaka Hattori [Japon] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Werner Poewe [Autriche] ; Mark Stacy [États-Unis] ; Eduardo Tolosa [Espagne] ; Haitao Gao [États-Unis] ; Jennifer Nagel [Suisse] ; Martin Merschhemke [Suisse] ; Ana Graf [Suisse] ; Christopher Kenney [États-Unis] ; Claudia Trenkwalder [Allemagne]	AFQ056 in Parkinson patients with levodopa‐induced dyskinesia: 13‐week, randomized, dose‐finding study
000253 (2012)	K. Martinu [Canada] ; C. Degroot [Canada] ; C. Madjar [Canada] ; A. P. Strafella [Canada] ; O. Monchi [Canada]	Levodopa influences striatal activity but does not affect cortical hyper‐activity in Parkinson’s disease
000270 (2012)	L. Wang [États-Unis] ; N. P. Murphy [États-Unis] ; A. Stengel [États-Unis] ; M. Goebel-Stengel [États-Unis] ; D. H. St Pierre [Canada] ; N. T. Maidment [États-Unis] ; Y. Taché [États-Unis]	Ghrelin prevents levodopa‐induced inhibition of gastric emptying and increases circulating levodopa in fasted rats
000361 (2011)	James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada]	The selective mu‐opioid receptor antagonist adl5510 reduces levodopa‐induced dyskinesia without affecting antiparkinsonian action in mptp‐lesioned macaque model of Parkinson's disease
000380 (2011)	Diego Santos-García [Espagne] ; Mercedes Macías [Espagne] ; Miguel Llaneza [Canada] ; M Nica Grande [Espagne] ; Raúl De La Fuente-Fernández [Canada]	Serum vitamin B12 and folate levels in Parkinson's disease patients treated with duodenal levodopa infusion
000478 (2011)	Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Iiona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Thérèse Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse]	AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials
000488 (2010)	Cory Toth [Canada] ; Oksana Suchowersky [Canada] ; Douglas Zochodne [Canada]	Reply: Neuropathy as a potential complication of levodopa use in Parkinson's disease: A pharmacological and pharmacovigilance point of view
000490 (2010)	Adam Zaidel [Israël] ; Hagai Bergman [Israël] ; Ya'Acov Ritov [Israël] ; Zvi Israel Md [Israël]	Levodopa and subthalamic deep brain stimulation responses are not congruent
000537 (2010)	Tom H. Johnston [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Juha-Matti Savola [Suisse] ; Jonathan M. Brotchie [Canada]	The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates
000588 (2010)	Daniella Rylander [Suède] ; Martin Parent [Canada] ; Sean S. O'Sullivan [Royaume-Uni] ; Sandra Dovero [France] ; Andrew J. Lees [Royaume-Uni] ; Erwan Bezard [France] ; Laurent Descarries [Canada] ; M. Angela Cenci [Suède]	Maladaptive plasticity of serotonin axon terminals in levodopa‐induced dyskinesia
000590 (2010)	Galit Kleiner-Fisman [Canada] ; Andres Lozano [Canada] ; Elena Moro [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada]	Long‐term effect of unilateral pallidotomy on levodopa‐induced dyskinesia
000591 (2010)	Cory Toth [Canada] ; Kim Breithaupt [Canada] ; Shaohua Ge [Canada] ; Yanjun Duan [Canada] ; Joan M. Terris [Canada] ; Anita Thiessen [Canada] ; Samuel Wiebe [Canada] ; Douglas W. Zochodne [Canada] ; Oksana Suchowersky [Canada]	Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease
000595 (2010)	Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony E. Lang [Canada] ; C. Warren Olanow [Italie, États-Unis]	Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study
000623 (2010)	Tom H. Johnston [Canada] ; Anne Van Der Meij [Pays-Bas] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]	Effect of histamine H2 receptor antagonism on levodopa–induced dyskinesia in the MPTP‐macaque model of Parkinson's disease
000648 (2010)	Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Daniel Lévesque [Canada] ; Thérèse Di Paolo [Canada]	BDNF levels are not related with levodopa‐induced dyskinesias in MPTP monkeys
000793 (2009)	Robert A. Hauser [États-Unis] ; Michel Panisset [Canada] ; Giovanni Abbruzzese [Italie] ; Linda Mancione [États-Unis] ; Nalina Dronamraju [États-Unis] ; Algirdas Kakarieka [Suisse]	Double‐blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease
000901 (2008)	Cory Toth [Canada] ; Martin Sutton Brown [Canada] ; Sarah Furtado [Canada] ; Oksana Suchowersky [Canada] ; Douglas Zochodne [Canada]	Neuropathy as a potential complication of levodopa use in Parkinson's disease
000911 (2008)	Susan H. Fox [Canada] ; Anthony E. Lang [Canada]	Levodopa‐related motor complications—Phenomenology
000A05 (2007)	Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada]	Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa
000A45 (2007)	Giovanni Fabbrini [Italie] ; Jonathan M. Brotchie [Canada] ; Francisco Grandas [Espagne] ; Masahiro Nomoto [Japon] ; Christopher G. Goetz [États-Unis]	Levodopa‐induced dyskinesias
000A46 (2007)	Panida Piboolnurak [Canada, Thaïlande] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; Janis M. Miyasaki [Canada] ; Jean A. Saint-Cyr [Canada] ; Yu-Yan W. Poon [Canada] ; William D. Hutchison [Canada] ; Jonathan O. Dostrovsky [Canada] ; Elena Moro [Canada]	Levodopa response in long‐term bilateral subthalamic stimulation for Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "levodopa" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "levodopa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    levodopa
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022